tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RAPT Stock Latest News

RAPT Therapeutics Unveils Plans for RPT904 Development
Company AnnouncementsRAPT Therapeutics Unveils Plans for RPT904 Development
1d ago
8K
RAPT
RAPT Therapeutics Expands Board with New Appointments
PremiumCompany Announcements
RAPT Therapeutics Expands Board with New Appointments
16d ago
8K
RAPT
Rapt Therapeutics appoints Scott Braunstein, Ashley Dombkowski to board
PremiumThe Fly
Rapt Therapeutics appoints Scott Braunstein, Ashley Dombkowski to board
16d ago
RAPT
RAPT Therapeutics Executes 1-for-8 Reverse Stock Split
PremiumCompany Announcements
RAPT Therapeutics Executes 1-for-8 Reverse Stock Split
22d ago
8K
RAPT
RAPT Therapeutics trading halted, news pending
PremiumThe Fly
RAPT Therapeutics trading halted, news pending
23d ago
RAPT
Upcoming Stock Splits This Week (June 16 to June 20) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (June 16 to June 20) – Stay Invested
25d ago
NCI
RGC
Rapt Therapeutics announces effective date for 1-for-8 reverse stock split
Premium
The Fly
Rapt Therapeutics announces effective date for 1-for-8 reverse stock split
27d ago
RAPT
RAPT Therapeutics Announces Development Plans for RPT904
Premium
Company Announcements
RAPT Therapeutics Announces Development Plans for RPT904
1M ago
8K
RAPT
Rapt Therapeutics started at Buy at Clear Street on RPT904b opportunity
PremiumThe Fly
Rapt Therapeutics started at Buy at Clear Street on RPT904b opportunity
1M ago
NVS
CHRO
Rapt Therapeutics initiated with a Buy at Clear Street
PremiumThe Fly
Rapt Therapeutics initiated with a Buy at Clear Street
1M ago
RAPT
RAPT Therapeutics Faces Nasdaq Delisting Notice
PremiumCompany Announcements
RAPT Therapeutics Faces Nasdaq Delisting Notice
1M ago
8K
RAPT
Rapt Therapeutics price target lowered to $1 from $2 at UBS
PremiumThe Fly
Rapt Therapeutics price target lowered to $1 from $2 at UBS
2M ago
RAPT
Rapt Therapeutics assumed with a Buy at H.C. Wainwright
PremiumThe FlyRapt Therapeutics assumed with a Buy at H.C. Wainwright
2M ago
RAPT
RAPT Therapeutics: Promising Clinical Developments and Strong Financial Performance Justify Buy Rating
Premium
Ratings
RAPT Therapeutics: Promising Clinical Developments and Strong Financial Performance Justify Buy Rating
2M ago
RAPT
RAPT Therapeutics Reports Improved Q1 2025 Results
Premium
Company Announcements
RAPT Therapeutics Reports Improved Q1 2025 Results
2M ago
RAPT
Rapt Therapeutics reports Q1 EPS (8c), consensus (14c)
PremiumThe Fly
Rapt Therapeutics reports Q1 EPS (8c), consensus (14c)
2M ago
RAPT
Rapt Therapeutics appoints Jessica Savage as VP, clinical development
PremiumThe Fly
Rapt Therapeutics appoints Jessica Savage as VP, clinical development
3M ago
RAPT
RAPT Therapeutics Announces Board Restructuring in 2025
PremiumCompany Announcements
RAPT Therapeutics Announces Board Restructuring in 2025
3M ago
8K
RAPT
RAPT Therapeutics: Strategic Licensing and Strong Cash Position Support Buy Rating Despite Financial Loss
PremiumRatings
RAPT Therapeutics: Strategic Licensing and Strong Cash Position Support Buy Rating Despite Financial Loss
4M ago
RAPT
Promising Developments and Strategic Trials Boost RAPT Therapeutics’ Buy Rating
PremiumRatingsPromising Developments and Strategic Trials Boost RAPT Therapeutics’ Buy Rating
4M ago
RAPT
RAPT Therapeutics Focuses on RPT904 Development in 2025
Premium
Company Announcements
RAPT Therapeutics Focuses on RPT904 Development in 2025
4M ago
RAPT
Rapt Therapeutics reports Q4 EPS ($1.14), consensus (36c)
Premium
The Fly
Rapt Therapeutics reports Q4 EPS ($1.14), consensus (36c)
4M ago
RAPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >